Author: admin

[if gte mso 9] > < xml > normal 0 21 false false false MicrosoftInternetExplorer4 <!-[if gte mso 9] > < w:LatentStyles DefLockedState = “false” LatentStyleCount = “156” > <!-[if gte mso 10] > USP La Esperanza joins the Green Pact promoted by theVitoria-Gasteiz City Council environmental -the Green Covenant arises on the occasion of the European green capitalHe holds the city during 2012 vitoria-Gasteiz, 2012-may La Clínica USP La EsperanzaIt had acceded to the Green Pact promoted by the Town Hall of Vitoria-Gasteizto promote new commitments on environmental issues during the year 2012.In this sense, USP La Esperanza will develop different measures toincreased energy efficiency within the clinic while maintaining its qualitycare at all times. through this commitment, USP La Esperanza has received adistinctive which credited her as a member of the Green Pact and as part ofEuropean Green Capital 2012. This distinctive reinforces the continuous commitment tofrom USP La Esperanza has been doing for the protection of the environment andsustainable development in our environment, one of the slogans of the USP groupHospitals. the Covenant green of the Town Hall of Vitoria-Gasteiz arises withreason for the European green capital holding the city during 2012 and itsobjective is to promote the collaboration of the business fabric of Vitoria in the yearGreen Capital. For the consistory, this title becomes oneopportunity that companies move forward in its environmental commitments,share their experiences...

[if gte mso 9] > < xml > normal 0 21 false false false MicrosoftInternetExplorer4 <!-[if gte mso 9] > < w:LatentStyles DefLockedState = “false” LatentStyleCount = “156” > <!-[if! mso] > <!-[if gte mso 10] > SEDISA and Grünenthal renewed their partnership agreement Spain, may of 2012- after a year of successful collaboration, SEDISA and Grünenthal renewed its agreement ofcollaboration to continue promoting theproper management of pain in the health system Spanish and increase theawareness of society about this disease. this consolidated Alliance between the laboratory and the collective of professionals dedicated to themanagement of health, will be reflected in the implementation of conferencesautonomous, and in participation in the 18 national Congress of hospitals thatbe held in Bilbao in the month of February 2013, under the motto creating valuesustainable ’ with all this,Grünenthal will continue betting on working together and encouraging allthose projects that contribute to improving the quality of life of thepatients with pain, in line with the interests and needs of societieshealth-related. About Grünenthal the Group Grünenthal is a pharmaceutical companyInternational, independent and family-owned research-basedHeadquartered in Aachen, Germany. Taking advantage of its leading position inthe area of the treatment of pain, its objective is to become the companymore focused on the patient in order to be a leader in therapeutic innovation. Grünenthal is one of the last five companiespharmaceutical based on research with headquarters in Germany,...

record for nominations to award Banco Sabadell to biomedical research A total of 56 researchers from across the country choose the prestigious award, which fails on 29 May. The provision of the prize, of 50,000 euros, in a difficult economic time for science, explains the success of the call Spain, 2012-may as many nominations as this year had registered in any of the six previous editions of Banco Sabadell Prize: 18 scientists from Catalonia and the rest of Spain 38under the age of 42, they compete in this edition to be recognition of a jury made up of the most prominent exponents of the biomedical research in our country. Nominations come from the best centers of research, universities and hospitals in Spain and confirm the prestige achieved by Banco Sabadell Prize for biomedical research among the scientific community in our country. The uniqueness of the prize, worth 50,000 euros, in a difficult economic time for research, also explains the success of the call. The failure of the prize will announce it the President of the jury, Dr. Carlos López-Otín, next Tuesday day 29 in Madrid and the award ceremony will be on June 26 in Barcelona. The prize is awarded to a young researcher career and intends to cooperate with the present and the future of biomedical science in our country. Dato: Number of candidates throughout the history of...